Description
Recombinant monoclonal antibody to Her2/neu. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the phage display antibody HerG1M. This reformatted human antibody was made using the variable domain sequences of the original Human VHH format, for improved compatibility with existing reagents, assays and techniques.
Target
Her2/neu
Target Alias Names
CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2
Isotype/Mimetic
IgG1-Fc Fusion
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression